Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07687511

Oral Microbiota and Muscle Function in the Ageing Subject

Ageing of the general population may be a risk factor for various complications, including sarcopenia. Sarcopenia is a progressive loss of muscle mass and muscle strength, leading to a decrease in functional capacities. It affects between 0.7% and 16% of European adults over 70 years of age (1). Recent studies suggest that the faecal microbiota may be altered with ageing but also according to sarcopenic status. Furthermore, no study has currently published data on the relationship between salivary microbiota and sarcopenic status. The main hypothesis of this study is that a decrease in salivary microbiota richness could be associated with impaired handgrip strength in the ageing subject.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

70 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rouen University Hospital

Rouen, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female adult volunteer, over 70 years of age
  • Non-hospitalised
  • Having read and understood the information letter and signed the consent form
  • Affiliated with a Social Security scheme

Exclusion criteria

  • Already included in an interventional drug clinical trial
  • Unable to understand and complete the questionnaires
  • Deprived of liberty by an administrative or judicial decision or protected adult subject (under guardianship, curatorship or judicial protection order)
  • Receiving antibiotic treatment or having received antibiotic treatment during the previous 3 months
  • Taking or having taken probiotics during the previous 3 months
  • Having undergone colonic lavage/bowel cleansing during the previous 3 months
  • Presenting one of the following situations likely to alter the microbiota: active cancer, eating disorders, exclusive vegetarian diet, history of digestive surgery
  • Having a cardiac pacemaker
  • Living in a nursing home for dependent elderly persons (EHPAD)

Treatment and study plan

Salivary and fecal microbiota sampling and muscle strength assessment

Procedure

Collection of saliva and stool samples for microbiota analysis and assessment of handgrip strength in adults aged over 70 years.

Primary outcomes

  1. Salivary microbiota richness

    Time frame: baseline

    Salivary microbiota richness (gene richness/alpha diversity) measured from saliva samples.

Secondary outcomes

  1. Fecal microbiota diversity

    Time frame: 15 days

    Assessment of fecal microbiota diversity from stool samples and its association with maximal handgrip strength.

  2. Title: Fecal microbiota richness

    Time frame: 15 days

    Assessment of fecal microbiota richness according to handgrip strength and sarcopenia status.

  3. Salivary microbiota diversity

    Time frame: 15 days

    Assessment of salivary microbiota diversity from saliva samples and its association with maximal handgrip strength.

  4. Fecal microbiota richness according to sarcopenia status

    Time frame: 15 days

    Comparison of fecal microbiota richness between participants with and without sarcopenia.

  5. handgrip strength

    Time frame: 15 days

    Identification of microbiological and clinical factors associated with lower maximal handgrip strength.

  6. Risk factors associated with low microbiota genomic diversity

    Time frame: 15 days

    Identification of factors associated with reduced microbial gene richness and diversity in saliva and stool samples.

Study contacts

Contact information is provided by the study sponsor or research team.

HERVET

CONTACT

[email protected]

Prof. DECHELOTTE

CONTACT

[email protected]

+33 2 32 88 56 70

Sponsors and collaborators

Lead sponsor

University Hospital, Rouen

Other

Registry information

Official study title

Oral Microbiota and Muscle Function in the Ageing Subject: MYOBIOTA Study

Acronym: MYOBIOTA

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Jul 7, 2026
Registry last updated
Jul 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.